Annual Report

Overview

The report highlights BioInvent's advancement of its lead programs BI-1808 and BI-1206 into mid-stage clinical development during 2025. It also describes the company's ISO 26000 verification and prioritization of four UN Sustainable Development Goals. Financially, the report records consolidated net sales of SEK 226,495 thousand and year-end employment of 109 full-time-equivalent employees.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2025
Period: 1 January 2025 – 31 December 2025
Language: English
Pages
File size

Materiality

Assessment
Basis

Assurance

Level
Standard
Scope
Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services